| CTRI Number |
CTRI/2022/07/044118 [Registered on: 19/07/2022] Trial Registered Prospectively |
| Last Modified On: |
18/07/2022 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Observational |
| Study Design |
Other |
|
Public Title of Study
|
Study of COVID-19 in terms of Ayurveda |
|
Scientific Title of Study
|
Etiopathological study of COVID-19 in terms of Ayurveda |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Ruby Rani Agarwal |
| Designation |
Professor and H.O.D. |
| Affiliation |
Rishikul Campus Uttarakhand Ayurved University Haridwar |
| Address |
OPD No. 21 & IPD, Department of Rog Nidan Avum Vikriti Vigyan, Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Hardwar
UTTARANCHAL
249401
India |
| Phone |
9456100745 |
| Fax |
|
| Email |
ruby6758@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Ruby Rani Agarwal |
| Designation |
Professor and H.O.D. |
| Affiliation |
Rishikul Campus Uttarakhand Ayurved University Haridwar |
| Address |
OPD No. 21 & IPD, Department of Rog Nidan Avum Vikriti Vigyan, Rishikul Campus, Uttarakhand Ayurved University, Haridwar
UTTARANCHAL
249401
India |
| Phone |
9456100745 |
| Fax |
|
| Email |
ruby6758@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
Dr Divya Rani |
| Designation |
P.G. Scholar |
| Affiliation |
Rishikul Campus, Haridwar, Uttarakhand Ayurveda University |
| Address |
OPD No. 21 & IPD, Department of Rog Nidan Avum Vikriti Vigyan, Rishikul Campus, Uttarakhand Ayurved University, Haridwar
Hardwar
UTTARANCHAL
249401
India |
| Phone |
8630927448 |
| Fax |
|
| Email |
divyarani097@gmail.com |
|
|
Source of Monetary or Material Support
|
| OPD No. 21 & IPD, Department of Rog Nidan Avum Vikriti Vigyan, Rishikul Campus, Uttarakhand Ayurved University, Haridwar |
|
|
Primary Sponsor
|
| Name |
Uttarakhand Ayurved University |
| Address |
Uttarakhand Ayurved University, Harrawala, Dehradun |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Divya Rani |
Rishikul Campus Uttarakhand Ayurved University |
OPD No. 21 and IPD, Department of Roga Nidan avum Vikriti Vigyan, Rishikul Campus Uttarakhand Ayurved University haridwar
Hardwar
UTTARANCHAL |
8630927448
divyarani097@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: B972||Coronavirus as the cause of diseases classified elsewhere, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details |
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1. Patient having previously positive RT-PCR.
2. Patient of age group 20-70 years of age of both sexes.
|
|
| ExclusionCriteria |
| Details |
1. Patient of age group less than 20 and more than 70 years.
2. Patient with previously negative RT-PCR. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Study of etiological factors of COVID-19 in Ayurveda |
1 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Study of pathogenesis of COVID-19 in terms of ayurveda |
1 month |
|
|
Target Sample Size
|
Total Sample Size="100"
Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
22/07/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1"
Months="6"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Today, the world is facing a major health challenge in the form of the COVID-19 pandemic, which is highly contagious and still untreated. Although many medications are used to alleviate symptoms of COVID-19, there is no established medication for this purpose. The COVID-19 pandemic is considered a type of Janpadodhvaṃsaaccording to Ä€yurveda. According to Ä€cÄryaCaraka, In Janpadodhvaṃsa person having distinct pá¹›aká¹›ti (constitution), ÄhÄra(diet), deha(body),Bala(strength),sÄtmya(mental strength), mana (mind)and Vaya(age) may be affected by one particular disease.. Therefore to prevent and treat COVID-19, the study of NidÄna and Sampá¹›aptiis very important. COVID-19 is a newly emerging disease and its causes, pathogenesis, prevention, and management is very less known. Ä€yuá¹›vedika medicines may give a significant contribution to the prevention and treatment of COVID 19. So to make our preventive measures and Ä€yuá¹›vedika treatment more precise, knowledge of the etiopathogenesis of COVID-19 is the need of the hour. |